PROCEPT BioRobotics Corporation Common Stock (PRCT) is a publicly traded Healthcare sector company. As of August 8, 2026, PRCT trades at $20.32 with a market cap of $1.15B and a P/E ratio of -10.89. PRCT moved +1.85% today. Year to date, PRCT is -33.65%; over the trailing twelve months it is -48.45%. Its 52-week range spans $16.67 to $92.92. Analyst consensus is buy with an average price target of $27.83. Rallies surfaces PRCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
9 analysts cover PRCT: 0 strong buy, 4 buy, 4 hold, 1 sell, and 0 strong sell. The consensus rating is buy. The average price target is $27.83.
| Metric | Value |
|---|---|
| Price | $20.32 |
| Market Cap | $1.15B |
| P/E Ratio | -10.89 |
| EPS | $-1.94 |
| Dividend Yield | 0.00% |
| 52-Week High | $92.92 |
| 52-Week Low | $16.67 |
| Volume | 1.58M |
| Avg Volume | 0 |
| Revenue (TTM) | $337.34M |
| Net Income | $-109.75M |
| Gross Margin | 64.22% |
9 analysts cover PRCT: 0 strong buy, 4 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $27.83.